APA (7th ed.) Citation

Hirakawa, Y., Arima, H., Zoungas, S., Ninomiya, T., Cooper, M., Hamet, P., . . . Chalmers, J. (2014). Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: The ADVANCE trial. Diabetes care, 37(8), 2359. https://doi.org/10.2337/dc14-0199

Chicago Style (17th ed.) Citation

Hirakawa, Yoichiro, et al. "Impact of Visit-to-visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-cause Mortality in Type 2 Diabetes: The ADVANCE Trial." Diabetes Care 37, no. 8 (2014): 2359. https://doi.org/10.2337/dc14-0199.

MLA (9th ed.) Citation

Hirakawa, Yoichiro, et al. "Impact of Visit-to-visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-cause Mortality in Type 2 Diabetes: The ADVANCE Trial." Diabetes Care, vol. 37, no. 8, 2014, p. 2359, https://doi.org/10.2337/dc14-0199.